chemotaxis of T cells and phagocytic cells to areas of inflammation (Power and Wells, 1996) . While CCR5 expression appears to be largely restricted to cells of the hematopoietic lineage (Alkhatib et al., 1996; Deng Summary et al., 1996; Samson et al., 1996) , Fusin is expressed on a wide variety of CD4-positive and -negative cells in Several members of the chemokine receptor family a number of tissues including brain, lung, and spleen have been shown to function in association with CD4 (Federsppiel et al., 1993; Loetscher et al., 1994) . Thus, to permit HIV-1 entry and infection. However, the during the course of HIV-1 infection, changes in the mechanism by which these molecules serve as CD4-utilization of particular cofactors may enable viruses to associated cofactors is unclear. In the present report, infect an increasing number of CD4-positive target cells. we show that one member of this family, termed Fusin/ However, while the utilization of these molecules follow-CXCR4, is able to function as an alternative receptor ing CD4 binding is likely to have an important role in for some isolates of HIV-2 in the absence of CD4. This determining the tropism of particular viral isolates, the conclusion is supported by the finding that (1) CD4-mechanism by which chemokine receptors interact with independent infection by these viruses is inhibited by CD4 and the viral envelope glycoprotein during infection an anti-Fusin monoclonal antibody, (2) Fusin expresis unclear. While it has been hypothesized that the envesion renders human and nonhuman CD4-negative cell lope glycoprotein may associate with one or more of lines sensitive to HIV-2-induced syncytium induction these 7tm proteins following CD4 binding (Choe et al., and/or infection, and (3) Fusin is selectively down-1996; Deng et al., 1996; Doranz et al., 1996; Feng et al. , regulated from the cell surface following HIV-2 infec-1996), a direct interaction between these molecules has tion. The finding that one chemokine receptor can not been shown.
function as a primary viral receptor strongly suggests
In addition to studies of CD4-dependent infection, that the HIV envelope glycoprotein contains a binding several reports have shown that some HIV isolates can site for these proteins and that differences in the affinity and/or the availability of this site can extend the infect lymphoid (Clapham et al., 1992; McKnight et al., 1994 ) and nonlymphoid cells (Tateno et al., 1989 ; Ikeuchi host range of these viruses to include a number of CD4-negative cell types.
et al Harouse et al., 1991; Clapham et al., 1992) in the absence of CD4. These studies are likely to be 12G5, a Monoclonal Antibody That Inhibits CD4-Independent Infection by HIV-2 relevant to increasing evidence in humans (Wiley et al., 1986; Moses et al., 1993; Bagasra et al., 1996; Living- In an effort to analyze interactions between cellular molecules and viral envelope glycoproteins, an anti-cellular stone et al., 1996) and nonhuman primates (Mankowski et al., 1994; Dean et al., 1996 ) that CD4-negative cells MAb termed 12G5 was derived that was able to inhibit syncytium induction by HIV-2/vcp on CD4-negative cell can be targets for HIV infection in vivo. In general HIV infection of CD4-negative cells proceeds slowly and lines (see Experimental Procedures and Figure 2A ). This MAb also inhibited syncytium induction by CP-MAC, a without cytopathic effects, most likely indicating the relatively inefficient use of an alternative receptor. Such is biological variant of SIVmac that has been shown to be highly infectious and fusogenic for Sup-T1 cells in a the case for the glycolipid galactosylceramide, which can serve as an alternative receptor on human glial and CD4-dependent manner (LaBranche et al., 1994 ) ( Figure  2A ). 12G5 was shown by FACS analysis to react with colon carcinoma cell lines (Harouse et al., 1991) . However, particularly for some isolates of HIV-2, infection of several CD4-positive and -negative human hematopoietic cell lines (Table 1 ) and with unfractionated human CD4-negative cells can occur rapidly and with extensive cell fusion (Clapham et al., 1992) . The highly cytopathic peripheral blood lymphocytes (not shown). Reactivity was also seen with some nonhematopoietic human cell nature of these infections has suggested that these isolates are able to utilize one or more alternative receptors lines including HeLa (cervical carcinoma) and RD (rhabdomyosarcoma), but not HOS (osteosarcoma) or U87 with high efficiency. However, the identity of these receptors has remained unknown.
(glial) cells (Table 1) . No reactivity was seen on the murine myeloma line SP2 or the other nonhuman cell lines In the present study, we show that isolates of HIV-2 that are able to infect a number of CD4-negative cells shown in Table 1 .
In addition to inhibiting cell fusion, 12G5 also neutralutilize the HIV-1 cofactor, Fusin, as a primary receptor in the absence of CD4. We show that the highly cytopathic, ized infection by HIV-2/vcp and CP-MAC when preincubated with appropriate target cells. CP-MAC infection CD4-independent infection exhibited by these viruses is inhibited by a novel monoclonal antibody to Fusin and of Sup-T1 cells was readily inhibited by antibody concentrations of 1 g/ml while somewhat higher concenthat the introduction of Fusin alone into a variety of human and nonhuman CD4-negative cells renders them trations (5-20 g/ml) were required to inhibit HIV-2/vcp infection of CD4-negative lines including BC7, Nalm6, fully permissive for HIV-2-induced syncytium induction and infection. We also show that the cloned HIV-2 env and Daudi ( Figure 2B ). Infection of these cell types was not inhibited by IgG 2a monoclonal antibodies that were gene induced syncytium formation of nonhuman cells that expressed Fusin in the absence of CD4. Finally, as isotype matched for 12G5 (not shown). Although 12G5 frequently caused cell clumping (Figure 2A ), no inhibidescribed for numerous viral receptors, we demonstrate that Fusin is selectively down-regulated from the cell tory effects were seen on cell growth and no toxic effects were apparent when cells were cultured in antibody surface following infection by these HIV-2 isolates. These findings strongly suggest that the HIV envelope concentrations as high as 50 g/ml (not shown). 12G5 also inhibited two other HIV-2 isolates, HIV-2/ glycoprotein contains a binding site for chemokine receptor proteins and that differences in the affinity and/ Rod-A and HIV-2/Rod-B, that have been shown to induce fusion on CD4-negative cell lines including Daudi or the availability of this site can markedly extend the host range of these viruses to include a number of CD4-and RD (Clapham et al., 1992) . HIV-2/Rod-A infectivity has been shown to be enhanced by preincubation with negative cell types. soluble CD4 (sCD4) while HIV-2/Rod-B induces syncytia on these CD4-negative cells without sCD4. As shown Results in Table 2 , 12G5 inhibited cell fusion at concentrations Ն5 g/ml when H9 cells chronically infected by HIVDerivation of an HIV-2 Variant That Infects Cells in the Absence of CD4 2/Rod-A or /Rod-B were cultured in the presence or absence of sCD4, respectively. Inhibition was also seen To study receptors involved in CD4-independent infection, a biological variant of HIV-2, termed HIV-2/vcp, of another HIV-2 isolate, HIV-2/CBL-23 that induces syncytia on RD cells following preincubation with sCD4 was derived from the HIV-2/NIH-z isolate (Zagury et al., 1988 ) (see Figure 1 ). HIV-2/vcp was shown to infect a (Table 2 ) (Clapham et al., 1992) . Therefore, in addition to its anti-viral effects on CP-MAC and HIV-2/vcp, 12G5 number of CD4-negative lymphoid cell lines of T-(BC7, HSB, CEMss4Ϫ) and B-(Daudi and Nalm6) cell origin inhibited infection and/or cell fusion for two other genetically distinct isolates of HIV-2 on CD4-negative target ( Figure 1A ) as well as the nonlymphoid rhabdomyosarcoma line RD (not shown). As expected, no infection cells. was seen when these cell types were inoculated with the T cell line-tropic isolate HIV-1/LAI ( Figure 1A ). In MAb 12G5 Reacts with Fusin addition, anti-CD4 monoclonal antibodies (MAbs) were Although 12G5 was shown to react with the cell surface not able to inhibit infection of BC7 ( Figure 1B) , Daudi or by FACS, efforts to immunoprecipitate or immunoblot Nalm6 cells (not shown), or cell-to-cell fusion between the antigen under a variety of conditions were unsuc-HIV-2/vcp-infected cells and uninfected BC7 cells (Fig- cessful. However, following the identification of Fusin as ure 1C). Similar to other HIV-2 isolates that can infect a CD4-associated accessory factor for T cell line-tropic CD4-negative cells (Clapham et al., 1992) , HIV-2/vcp HIV-1 isolates (Feng et al., 1996) , we evaluated 12G5 for infected the majority of these cell types with extensive reactivity with this protein. U87 cells that stably excell fusion and killing, indicating the highly efficient use of one or more alternative receptors (not shown).
pressed either Fusin or the CC-chemokine receptor, CCR1, were derived and evaluated by FACS for 12G5 cells transduced with the control vector alone ( Figure  3A ). Similar results were seen for human 293T cells in binding. Remarkably, 12G5 reacted strongly with U87 cells that expressed Fusin while only background stainwhich Fusin was transiently expressed by transfection (not shown). ing was detected on U87 cells that expressed CCR1 or To determine if 12G5 reacted with other chemokine Analysis of Fusin-expressing CHO cells was also performed by immunofluorescence confocal microscopy of receptor family members, a panel of CHO cell lines was used that stably expressed either Fusin, CC-chemokine intact cells. As shown in Figure 3C , staining was observed on cells expressing HA-tagged Fusin while no receptors (CCR1, CCR2b, CCR3, CCR4, or CCR5), or CXC-chemokine receptors (IL8R-A or IL8R-B). The rereactivity was seen with cells expressing HA-tagged IL8R-B receptors. Expression of each protein could be combinant receptors in these CHO lines were expressed either untagged or tagged at the amino terminus with the detected using an HA-specific MAb, and no staining was observed with an anti-CD4 MAb used as a control influenza hemagglutinin (HA) epitope. Surface binding assays were performed using to both human and nonhuman cells that expressed re- 
Cells were stained for FACS analysis with saturating amounts of 12G5 (10-15 g/ml). Reactivity was compared to an isotype-matched control MAb. A panel of anti-CD4 MAbs was used to evaluate CD4 expression including OKT4, OKT4A, and #19. Plus sign indicates reactivity Ն3-fold background. CEMss4 Ϫ cells are a CD4-negative variant of CEMss derived by serially panning with an anti-CD4 MAb, sorting for CD4-negative cells and cloning by limiting dilution. BC7 cells were cloned by limiting dilution from a culture of Sup-T1 cells chronically infected by HIV-1/NL4-3 and show no detectable HIV-1, as determined by p24 production, coculture assay with susceptible cells, and PCR of genomic DNA with virus-specific primers (M. J.
E. and J. A. H., unpublished). Lysates of BC7 and CEMss4
Ϫ exhibit no detectable CD4 protein by Western blot using a rabbit anti-CD4 antiserum.
combinant Fusin, strongly suggesting that this antibody 12G5 by FACS analysis (Table 1 ) and have no detectable reacts specifically with the human Fusin protein.
Fusin mRNA (Feng et al., 1996; A. McKnight et al., submitted) . As shown ( Figure 4A ), when Fusin-expressing U87 cells were cocultured with HIV-2/vcp-infected BC7 Fusin Serves as an Alternative Receptor cells, extensive cell fusion was seen. Preincubating cells for HIV-2/vcp in the Absence of CD4 with 12G5 (10 g/ml) completely abolished syncytium Because 12G5 was able to inhibit CD4-independent information. No fusion was seen when similar cocultures fection by some HIV-2 isolates, the above findings sugwere performed with nontransduced U87 cells or with gested that Fusin was functioning as an alternative re-U87 cells that expressed only recombinant CD4 (Figure ceptor for these viruses. In order to test this hypothesis, 4A). Similar results were seen for murine NIH 3T3 fibro-U87 cells that stably expressed either recombinant Fusin blast cells that stably expressed Fusin in the absence or CD4 were evaluated in coculture assays for their abilof CD4 (not shown). ity to form syncytia with HIV-2/vcp-infected cells. As Experiments were performed to determine if recombipreviously noted, U87 cells exhibited no reactivity with nant Fusin could mediate productive infection by cellfree HIV-2/vcp. Control U87 cells or U87 cells that stably expressed either Fusin or CD4 were incubated with HIV- or Fusin with CD4. As shown (Figure 5 ), the HIV-2/vcp that inhibited syncytium formation by Ͼ95%.
envelope glycoprotein fused with Fusin-expressing tar- ( Weiss, 1993) . Indeed, the observation that CD4 was selectively down-regulated on HIV-1-infected cells proTaken together, these results show that Fusin can serve as an alternative receptor for some isolates of HIV-2 in vided the initial evidence that CD4 was a receptor for this virus . Down-regulation of the absence of CD4 on human as well as nonhuman target cells. These findings also demonstrate that for CD4 and other viral receptors by envelope glycoproteins has been attributed to the formation of intracellular com-HIV-2/vcp, CD4 alone is not sufficient to permit viral entry and indicate that the utilization of Fusin is an obligplexes between envelope molecules and the cellular receptors and/or to the blocking of binding sites on atory step for this virus during infection. Where indicated target cells were also infected with pT4, which constitutively expresses CD4 from the CMV promoter. Luciferase activity as an indication of cell fusion is indicated in terms of relative light units (RLU) as described previously (Doranz et al., 1996) . marked and selective reduction in 12G5 binding. Although this experiment could not distinguish between the loss of surface Fusin and blocking of the 12G5 epitope, this result is entirely consistent with other evidence noted above that Fusin is serving as a primary viral receptor for HIV-2/vcp. As expected, CD4 was downregulated 95% and 98% on HIV-2/vcp and CP-MAC- regulation occurs when it is utilized as a primary receptor units) and serial determination of RT activity performed at the indiin the absence of CD4 but not as a CD4-associated cated time points. Infection is only seen for Fusin-expressing cells. Extensive syncytium formation and cell killing were also observed coreceptor (see Discussion).
in this culture that correlated with the time of RT production (data not shown).
Discussion
In this report we demonstrate that Fusin, the recently receptors that are expressed on the cell surface (Hoxie described cofactor for T cell line-adapted isolates of et al., 1986; Crise et al., 1990; Schneider-Schaulies et HIV-1, is able to function as an alternative receptor for al. , 1995) . Given the evidence that Fusin was serving as some isolates of HIV-2 in the absence of CD4. Two a primary receptor for HIV-2/vcp, we utilized 12G5, to genetically distinct isolates of HIV-2 that exhibited CD4-determine if this molecule was down-regulated during independent infection of human lymphoid and non-HIV-2/vcp infection. lymphoid cells (HIV-2/vcp and HIV-2/Rod-B) were inhib-BC7, Daudi, and Nalm6 cells that were either uninited in virus neutralization and/or syncytium induction fected or chronically infected by HIV-2/vcp were evaluassays by 12G5, a MAb shown to be specific for Fusin. ated for Fusin expression by FACS analysis with 12G5.
In addition, U87 cells that were resistant to HIV-2/vcp As shown in Figure 6 , on HIV-2/vcp-infected cells, 12G5 became fully permissive for syncytium formation and binding was reduced 98%, 79%, and 87% compared to infection following transduction with recombinant Fusin uninfected cells. In contrast, no reduction was seen in in the absence of CD4. This effect was completely deexpression of HLA class I or transferrin receptors using pendent on the viral envelope glycoprotein, since a specific MAbs (not shown). Thus, for several CD4-negacloned HIV-2/vcp env gene mediated syncytium formation on QT6 cells when Fusin was expressed without tive lymphoid cells, HIV-2/vcp infection produced a Cell lines that were either uninfected or infected by the viruses indicated were evaluated for surface reactivity by FACS either with an isotypematched control MAb or 12G5 (10 g/ml), and the mean channel fluorescence intensity (MCF) shown for each cell type. Cells were 100% infected, as determined by immunofluorescence microscopy using an HIV-2/SIVmac p27gag -specific MAb. Loss of 12G5 reactivity is seen on HIV-2/vcp-infected but not CP-MAC-infected cells. The data are representative of three experiments from two separate infections.
CD4. Finally, as is the case for many viral receptors, HIVinfection, it is not down-regulated by CP-MAC, a virus that still requires CD4 for infection and cell fusion (Figure 2/vcp infection produced a selective down-regulation of
Fusin from the cell surface. 6). Recent studies have also shown that HIV-1/LAI, which requires Fusin in association with CD4 to infect Although several members of the chemokine receptor family have been shown to function in association with cells, induces minimal (<10%) down-regulation of surface Fusin on chronically infected cells (J. A. H., unpub-CD4 to permit viral entry (Alkhatib et al., 1996; Choe et al., 1996; Deng et al., 1996; Doranz et al., 1996; Dragic lished data) . If the ability of HIV-2/vcp to utilize Fusin as an alternative receptor corresponds to a higher affinity et Feng et al., 1996) , the precise mechanism of action of these proteins as coreceptors has not been interaction with the envelope glycoprotein, it follows that the transport of Fusin to the cell surface during synthesis established. One recent report mapped a determinant for coreceptor utilization to the hypervariable V3 loop could be inhibited in infected cells as has been shown to occur for CD4 (Crise et al., 1990 ; Jabbar and Nayak, of the gp120 surface envelope glycoprotein (Choe et al., 1996) . Additional studies using chimeric receptors 1990; Koga et al., 1990) . In contrast, for viruses that might bind more weakly to Fusin (i.e., in a CD4-depenbetween CCR5 and CCR2b have identified regions on CCR5 that are required for this protein to function as a dent manner) an intracellular interaction could either fail to occur or not be sufficiently stable to interfere with CD4 coreceptor for M-and dual-tropic HIV-1 isolates (Rucker et al., 1996) . These findings are consistent with the surface expression of Fusin. Viruses such as HIV-2/ vcp and HIV-2/Rod-B will be particularly useful in biothe view that an initial interaction of the envelope glycoprotein with CD4 produces a conformational change chemical assays to evaluate direct interactions of their envelope glycoproteins with Fusin and perhaps other that facilitates a secondary interaction with one or more 7tm proteins (Deng et al., 1996; Doranz et al., 1996) . members of the chemokine receptor family. Although in general, HIV and SIV isolates are CD4-However, it is also possible that 7tm proteins facilitate viral entry indirectly by affecting the cell membrane and/ dependent, our finding that two genetically distinct isolates of HIV-2 can infect Fusin-expressing cells indepenor CD4 without contacting the viral envelope molecule (Berson et al., 1996; Choe et al., 1996) . Our finding, that dent of CD4 indicates that this property is not restricted to a single laboratory variant. Indeed, as initially reat least one member of this family can serve as a primary receptor in the absence of CD4 for a subset of HIV-2 ported, HIV-2s with only a minimal passage history have exhibited CD4-independence in vitro (Clapham et al., isolates, strongly suggests that these proteins interact directly with the viral envelope glycoprotein during entry. 1992). While the relevance of this finding for pathogenesis, if any, remains to be determined, it is possible that Moreover, the finding that a chemokine receptor, unlike CD4, can be both necessary and sufficient for viral entry, the ability of some HIV isolates to utilize a 7tm molecule as a primary receptor could have implications for pathoraises the intriguing possibility that these 7tm proteins may be primordial receptors for the primate lentiviruses.
genesis. Studies of tissues from HIV-infected humans (Wiley et al., 1986; Bagasra et al., 1996 ; Livingstone et Thus, the role of CD4 may simply be to direct the viral envelope glycoprotein onto these molecules where the al., 1996; Moses et al., 1993) and SIV-infected nonhuman primates in advanced stages of disease (Mankowski subsequent fusion reaction then occurs.
It remains to be determined what changes in the enveet al., 1994; Dean et al., 1996) have shown productive infection of cells that are apparently CD4-negative. Allope glycoprotein enable the HIV-2 variants that we have analyzed to bypass a requirement for CD4. Recent studthough it is possible that these cells do express a low level of CD4, our study raises the possibility that HIV ies of HIV-2/Rod-B have indicated that mutations in both gp120 as well as TM are required for this virus to infect could evolve in vivo to bypass CD4 and utilize at least some chemokine receptors directly to infect cells. Given CD4-negative cells (Reeves and Schulz, 1996) . These mutations could increase exposure of a binding site the expanding number of molecules that are part of the chemokine receptor family (Power and Wells, 1996) , and for a 7tm protein and/or increase the affinity of this interaction. Interestingly, although Fusin is down-reguthe ability of HIV isolates (Feng et al., 1996 ; Alkhatib et al., 1996; Dragic et al., 1996; Deng et al., 1996; Doranz lated by HIV-2/vcp in the context of CD4-independent described previously (Hoxie et al., 1986 (Hoxie et al., , 1988 LaBranche et al., et al., 1996; Choe et al., 1996) 
to interact with different 1994). CD4-negative T lymphoid lines HSB and CEMss4
Ϫ were promembers of this family, it is possible that direct, CD4-vided by David Weiner (University of Pennsylvania) and Carolyn independent interactions between envelope molecules Doyle (Duke University), respectively, and BC7 was derived from and 7tm proteins could occur in vivo on a variety of Sup-T1 cells, as described in Table 1 and SIV utilize 7tm molecules, either directly or in associ-U87 cells stably expressing recombinant Fusin, CCR1, or CD4 were derived as described previously (Deng et al., 1996) . Murine NIH 3T3 ation with CD4, will provide considerable insight into cells expressing either Fusin alone or Fusin and human CD4 were the molecular basis for differences in tropism among provided by D. Littman (New York University) (Deng et al., 1996) . these viruses. However, it is clear that coreceptor utilizaChinese Hamster Ovary cells (CHO-K1) expressing HA-tagged or tion is structurally complex and that a single envelope untagged human chemokine receptors were derived using cDNAs glycoprotein can interact with genetically divergent derived by RT-PCR and cloned into pcDNA1neo for expression in members of the chemokine receptor family (Choe et al., mammalian cells (Power et al., 1995) . Stable CHO lines expressing the chemokine receptors were derived by screening for reactivity Doranz et al., 1996) . Moreover, recent studies with cofactors in addition to Fusin are involved on particular cell types; (2) that post translational modifications occur
Viruses
An uncloned viral stock of HIV-2/NIH-z was provided by R. Gallo.
on Fusin that are relevant to its interaction with the cofactors and determinants of tropism for some HIV and SIV isolates.
Constructs
The availability of 12G5, which reacts with cell surface
The HIV-2/vcp env gene was PCR amplified from genomic DNA from HIV-2/vcp-infected HSB cells using the primer pair 5Ј-GGCTCA as well as intracellular Fusin, provides an important re- agent for basic studies of this receptor at the cellular and 5Ј-CTGCTGATATCGCTGTCCCTCACAGGAGGGCGAG-3Ј, and level including (1) its association with CD4 and other cloned into the eukaryotic expression vector pCR3.1 (Invitrogen).
surface molecules, (2) its distribution within tissues and
The BH8 env clone was provided by Dr. Pat Earl (NIH). Fusin and among subsets of hematopoietic cells, and (3) its partici-CD4 were expressed as previously described (Berson et al., 1996;  pation in cellular signal transduction pathways. We re- Doranz et al., 1996) . Frank Jirik (University of British Columbia) provided the IL8 receptor clone.
cently utilized 12G5 to demonstrate rapid internalization of Fusin on lymphoid cells in response to phorbol esters of HIV-1 (Golding et al., 1994 (Golding et al., , 1995 (1996) . Cellular reservoirs of HIV-1 in the central nerwhich require priming with soluble sCD4 to infect CD4-negative vous system of infected-individuals: identification by combination cells, H9 cells chronically infected with these viruses were preincuof in situ PCR and immunohistochemistry. AIDS 10, 573-585. bated with 5 g/ml of soluble CD4 prior to cocultivation with target Berson, J.F., Long, D., Doranz, B.J., Rucker, J., Jirik, F.R., and Doms, cells as previously described (Clapham et al., 1992) . Cell fusion R.W. (1996) . A seven-transmembrane domain receptor involved in induced by cloned env genes was quantitated using a luciferase fusion and entry of T cell-tropic human immunodeficiency virus type gene reporter assay described previously (Doranz et al., 1996) . In 1 strains. J. Virol. 70, 6288-6295. brief, HeLa effector cells were transfected with HIV env-containing Brass, L.F., Pizarro, S., Ahuja, M., Belmonte, E., Stadel, J.M., and constructs and infected with recombinant vaccinia virus encoding Hoxie, J.A. (1994) . Changes in the structure and function of the the T7 polymerase gene (provided by B. Moss, NIH). Target cells human thrombin receptor during receptor activation, internalization were quail QT6 cells that were transfected with a plasmid containing and recycling. J. Biol. Chem. 269, 2943-2952. the luciferase gene driven by a T7 promoter (Promega). Selected target cells were also transfected with pT4 which constitutively exChoe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., presses CD4 from the CMV promoter. Effectors and target cells Wu, L., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard, were mixed and allowed to fuse for 8 hr. Cells were then washed C., and Sodroski, J. (1996) . The ␤-chemokine receptors CCR3 and with PBS and lysed in 150 l reporter lysis buffer (Promega) and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-assayed for luciferase activity according to the instructions of the 1148. manufacturer.
Clapham, P.R., Blanc, D., and Weiss, R.A. (1991) . Specific cell surface requirements for the infection of CD4-positive cells by human Flow Cytometry immunodeficiency virus types 1 and 2 and by Simian immunodefiSurface expression of cell surface antigens was performed by FACS ciency virus. Virology 181, 703-715. analysis using a Becton-Dickinson FACScan flow cytometer as deClapham, P.R., McKnight, A., and Weiss, R.A. (1992) . Human immuscribed previously (LaBranche et al., 1994) . For experiments involvnodeficiency virus type 2 infection and fusion of CD4-negative huing adherent cells, cells were dislodged from plates by treatment man cell lines: induction and enhancement by soluble CD4. J. Virol. with PBS/1 mM EDTA. All HIV-or SIV-infected cell samples were 66, 3531-3537. fixed at 4Њ for 24 hr in 4% paraformaldehyde prior to analysis. Connor, R.I., and Ho, D.D. (1994) . Human immunodeficiency virus type 1 variants with increased replicative capacity develope during Iodinated Antibody Binding Assays the asymptomatic stage before disease progression. J. Virol. 68, Binding assays with iodinated 12G5 and iodinated 12CA5 were per-4400-4408. formed essentially as described (Pelchen-Matthews et al., 1989) .
Crise, B., Buonocore, L., and Rose, J.K. (1990) . CD4 is retained in 12G5 and 12CA5 were labeled with 125 I using Bolton and Hunter the endoplasmic reticulum by the human immunodeficiency virus reagent (Amersham, UK) to a specific activity of 390 and 550 Ci type 1 glycoprotein precursor. J. Virol. 64, 5585-5593. per mmol, respectively. Cells were cultured in 24-well plates and incubated with 1 nM 125 I-12G5 and 2 nM 12CA5 for 2-4 hr at 4ЊC, Dean, G.A., Reubel, G.H., and Pedersen, N.C. (1996) . Simian immuthen washed and the amount of bound antibody determined by nodeficiency virus infection of CD8ϩ lymphocytes in vivo. J. Virol. ␥-counting. Background levels of binding were determined by per-70, 5646-5650. forming assays in the presence of 100 nM unlabeled antibody.
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factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1
